Back to Search
WILLIAM GRIZZLE, MD
MD
Anatomic Pathology Physician
NPI: 1568407740Individual
Specialties, Licenses & Credentials
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
09454(AL)
Research & Publications (20)
the need for review and understanding of SELDI/MALDI mass spectroscopy data prior to analysis.
PMID 19305634·Cancer Inform·2005
8-other
BXD recombinant inbred mice represent a novel T cell-mediated immune response tumor model.
PMID 12209979·Int J Cancer·2002
7-preclinical
Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
PMID 11802199·Int J Cancer·2002
4-observational
Avoiding biohazards in medical, veterinary and research laboratories.
PMID 11549131·Biotech Histochem·2001
6-review
Molecular characterization of colorectal neoplasia in translational research.
PMID 11151060·Arch Pathol Lab Med·2001
6-review
Polyethylene glycosylated curcumin conjugate inhibits pancreatic cancer cell growth through inactivation of Jab1.
PMID 19395473·Mol Pharmacol·2009
8-other
Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
PMID 19610059·Int J Cancer·2009
4-observational
How to efficiently obtain human tissues to support specific biomedical research projects.
PMID 19435863·Cancer Epidemiol Biomarkers Prev·2009
6-review
Immunohistochemical expression of rabphilin-3A-like (Noc2) in normal and tumor tissues of human endocrine pancreas.
PMID 19212825·Biotech Histochem·2009
8-other
Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance.
PMID 19675137·Diabetes·2009
7-preclinical
Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.
PMID 19375853·Cancer Lett·2009
8-other
CXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growth.
PMID 19139127·Mol Cancer Ther·2009
7-preclinical
Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma.
PMID 19339276·Clin Cancer Res·2009
8-other
Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.
PMID 19289498·Mol Cell Biol·2009
7-preclinical
Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
PMID 19574765·Int J Gynecol Cancer·2009
8-other
Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
PMID 19109954·Gastroenterology·2009
7-preclinical
Induction of myeloid-derived suppressor cells by tumor exosomes.
PMID 19235923·Int J Cancer·2009
7-preclinical
Timing of consent for the research use of surgically removed tissue: is postoperative consenting acceptable?
PMID 19090013·Cancer·2009
8-other
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group.
PMID 19072545·J Proteome Res·2009
8-other
CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.
PMID 19363468·Cancer Gene Ther·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 619 19TH STREET SOUTH
BIRMINGHAM, AL 35233 - Phone
- (205) 934-4011
Quick Facts
- NPI
- 1568407740
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile